Yezi Zhu

2.9k total citations · 1 hit paper
31 papers, 2.1k citations indexed

About

Yezi Zhu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yezi Zhu has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Yezi Zhu's work include Prostate Cancer Treatment and Research (20 papers), Cancer, Lipids, and Metabolism (6 papers) and Hormonal and reproductive studies (5 papers). Yezi Zhu is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Cancer, Lipids, and Metabolism (6 papers) and Hormonal and reproductive studies (5 papers). Yezi Zhu collaborates with scholars based in United States, China and Taiwan. Yezi Zhu's co-authors include Wei Lou, Allen C. Gao, Chengfei Liu, Christopher P. Evans, Nagalakshmi Nadiminty, Jun Luo, Ramakumar Tummala, Chad Schwartz, Cameron M. Armstrong and Emmanuel S. Antonarakis and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yezi Zhu

31 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide

2017 340 citations Emmanuel S. Antonarakis, Changxue Lu et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yezi Zhu United States	22	1.2k	1.0k	764	421	237	31	2.1k
Baijun Dong China	30	726 0.6×	1.3k 1.3×	645 0.8×	378 0.9×	53 0.2×	90	2.2k
Yue Wu China	29	390 0.3×	1.0k 1.0×	428 0.6×	257 0.6×	182 0.8×	110	2.3k
Angela Alama Italy	30	617 0.5×	888 0.9×	623 0.8×	1.2k 2.9×	52 0.2×	101	2.4k
Vijay Pandey China	30	226 0.2×	1.4k 1.4×	706 0.9×	658 1.6×	226 1.0×	105	2.5k
Shibu Thomas United States	21	521 0.5×	634 0.6×	348 0.5×	412 1.0×	84 0.4×	71	1.5k
Lixia Xu China	30	399 0.3×	1.6k 1.6×	966 1.3×	622 1.5×	74 0.3×	106	2.8k
Jing Peng China	24	299 0.3×	1.6k 1.6×	599 0.8×	732 1.7×	60 0.3×	77	2.5k
Zhengxin Wang United States	32	517 0.4×	2.3k 2.3×	308 0.4×	440 1.0×	132 0.6×	71	3.2k
Meiju Ji China	35	388 0.3×	2.1k 2.0×	685 0.9×	784 1.9×	1.1k 4.6×	116	3.5k
Bo Cao China	20	371 0.3×	747 0.7×	267 0.3×	277 0.7×	128 0.5×	40	1.3k

Countries citing papers authored by Yezi Zhu

Since Specialization

Citations

This map shows the geographic impact of Yezi Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yezi Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yezi Zhu more than expected).

Fields of papers citing papers by Yezi Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yezi Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yezi Zhu. The network helps show where Yezi Zhu may publish in the future.

Co-authorship network of co-authors of Yezi Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yezi Zhu. A scholar is included among the top collaborators of Yezi Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yezi Zhu. Yezi Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Yezi, Susan L. Dalrymple, Ilsa M. Coleman, et al.. (2021). Correction to: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors. Oncogene. 40(11). 2148–2148. 1 indexed citations

Wang, Keliang, Jie Luo, Shuyuan Yeh, et al.. (2020). The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nature Communications. 11(1). 2689–2689. 52 indexed citations

Zhu, Yezi, Susan L. Dalrymple, Ilsa M. Coleman, et al.. (2020). Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors. Oncogene. 39(45). 6935–6949. 70 indexed citations

Zhu, Yezi & Jun Luo. (2020). Regulation of androgen receptor variants in prostate cancer. Asian journal of urology. 7(3). 251–257. 21 indexed citations

Zhao, Pei, Yezi Zhu, Liang Cheng, & Jun Luo. (2018). Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications. Asian journal of urology. 6(1). 109–113. 5 indexed citations

Bao, Jian, Yezi Zhu, Fenghe Wang, et al.. (2018). Adsorption of Tetracycline with Reduced Graphene Oxide Decorated with MnFe2O4 Nanoparticles. Nanoscale Research Letters. 13(1). 396–396. 60 indexed citations

Zhu, Yezi, et al.. (2018). Data augmentation using conditional generative adversarial networks for leaf counting in arabidopsis plants. TU/e Research Portal. 324. 46 indexed citations

Shu, Xi, Huiqin Liu, Yezi Zhu, et al.. (2018). An improved bulk acoustic waves chip based on a PDMS bonding layer for high-efficient particle enrichment. Microfluidics and Nanofluidics. 22(3). 8 indexed citations

Lokhandwala, Parvez M., Lisa Haley, Changxue Lu, et al.. (2016). Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory Setting. Journal of Molecular Diagnostics. 19(1). 115–125. 41 indexed citations

10.

Antonarakis, Emmanuel S., Changxue Lu, Brandon Luber, et al.. (2016). AR-V7 and efficacy of abiraterone (Abi) and enzalutamide (Enza) in castration-resistant prostate cancer (CRPC): Expanded analysis of the Johns Hopkins cohort.. Journal of Clinical Oncology. 34(15_suppl). 5012–5012. 11 indexed citations

11.

Zhu, Yezi, et al.. (2015). Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer. Clinical Cancer Research. 21(18). 4133–4142. 54 indexed citations

12.

Zhu, Yezi, Chengfei Liu, Yuanyuan Cui, et al.. (2014). Interleukin‐6 induces neuroendocrine differentiation (NED) through suppression of RE‐1 silencing transcription factor (REST). The Prostate. 74(11). 1086–1094. 58 indexed citations

13.

Liu, Chengfei, Wei Lou, Yezi Zhu, et al.. (2014). Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 20(12). 3198–3210. 295 indexed citations

14.

Zhu, Yezi, Chengfei Liu, Nagalakshmi Nadiminty, et al.. (2013). Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer. Molecular Cancer Therapeutics. 12(9). 1829–1836. 104 indexed citations

15.

Tummala, Ramakumar, Nagalakshmi Nadiminty, Wei Lou, et al.. (2013). Lin28 Promotes Growth of Prostate Cancer Cells and Activates the Androgen Receptor. American Journal Of Pathology. 183(1). 288–295. 25 indexed citations

16.

Tummala, Ramakumar, Nagalakshmi Nadiminty, Yezi Zhu, et al.. (2013). 1322 LIN28 PROMOTES GROWTH OF PROSTATE CANCER CELLS AND ACTIVATES THE ANDROGEN RECEPTOR. The Journal of Urology. 189(4S). 2 indexed citations

17.

Nadiminty, Nagalakshmi, Ramakumar Tummala, Wei Lou, et al.. (2012). MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth. PLoS ONE. 7(3). e32832–e32832. 147 indexed citations

18.

Zhu, Yezi, Ramakumar Tummala, Chengfei Liu, et al.. (2011). RhoGDIα suppresses growth and survival of prostate cancer cells. The Prostate. 72(4). 392–398. 12 indexed citations

19.

Nadiminty, Nagalakshmi, Ramakumar Tummala, Wei Lou, et al.. (2011). MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells. Journal of Biological Chemistry. 287(2). 1527–1537. 160 indexed citations

20.

Sun, Meng, Chengfei Liu, Nagalakshmi Nadiminty, et al.. (2011). Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. The Prostate. 72(1). 82–89. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact